3.4. Serum IL17A, IL17F, and TLR4 Levels in MASLD Patients Compared to Controls and Possible Associations with IL17A, IL17F, and TLR4 Polymorphisms. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.